Therefore, enhanced preoperative diagnostic techniques are warranted for accurate identification of HER2-positive breast cancer patients with a pCR after NAT, to pave the way for a surgery-free treatment strategy. The gene discussed is ERBB2; the disease is breast carcinoma.